JXSS1900048 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-08-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-12-15 | view |
JXSS1900047 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-08-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-12-15 | view |
JXSS1900050 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-08-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-12-15 | view |
JXSS1900049 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-08-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2021-12-15 | view |
JXSL2000113 | 注射用重组人凝血因子VIII Fc-血管性血友病因子-XTEN融合蛋白 | | Lyophilized | Biological Products | Import Drug Application | 2020-07-06 | 赛诺菲(中国)投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2020-07-04 | view |
JXSL2000116 | 注射用重组人凝血因子VIII Fc-血管性血友病因子-XTEN融合蛋白 | | Lyophilized | Biological Products | Import Drug Application | 2020-07-06 | 赛诺菲(中国)投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2020-07-04 | view |
JXSL2000112 | 注射用重组人凝血因子VIII Fc-血管性血友病因子-XTEN融合蛋白 | | Lyophilized | Biological Products | Import Drug Application | 2020-07-06 | 赛诺菲(中国)投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2020-07-04 | view |
JXSL2000115 | 注射用重组人凝血因子VIII Fc-血管性血友病因子-XTEN融合蛋白 | | Lyophilized | Biological Products | Import Drug Application | 2020-07-06 | 赛诺菲(中国)投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2020-07-04 | view |
JXSL2000111 | 注射用重组人凝血因子VIII Fc-血管性血友病因子-XTEN融合蛋白 | | Lyophilized | Biological Products | Import Drug Application | 2020-07-06 | 赛诺菲(中国)投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2020-07-04 | view |
JXSL2000114 | 注射用重组人凝血因子VIII Fc-血管性血友病因子-XTEN融合蛋白 | | Lyophilized | Biological Products | Import Drug Application | 2020-07-06 | 赛诺菲(中国)投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2020-07-04 | view |
JXSL1500015 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2015-04-17 | 精鼎医药研究开发(上海)有限公司 | Parexel China Co Ltd | Certificate Issued | 2017-12-06 | view |
JXSL1400062 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2015-01-04 | 精鼎医药研究开发(上海)有限公司 | Parexel China Co Ltd | Certificate Issued | 2016-08-01 | view |
JXSL1500014 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2015-04-17 | 精鼎医药研究开发(上海)有限公司 | Parexel China Co Ltd | Certificate Issued | 2017-12-06 | view |
JXSL1500013 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2015-04-17 | 精鼎医药研究开发(上海)有限公司 | Parexel China Co Ltd | Certificate Issued | 2017-12-06 | view |
JXSL1400061 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2015-01-23 | 精鼎医药研究开发(上海)有限公司 | Parexel China Co Ltd | Certificate Issued | 2016-08-01 | view |
JXSL1500012 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2015-04-30 | 精鼎医药研究开发(上海)有限公司 | Parexel China Co Ltd | Certificate Issued | 2017-12-06 | view |
CXSS1900042 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2019-11-19 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2021-07-28 | view |
CXSL1400060 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2014-07-11 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2016-01-14 | view |
CXSS1900043 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2019-11-19 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2021-07-28 | view |
CXSL1400061 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2014-07-11 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2016-01-14 | view |